Week Ahead In Pharma: FDA Decisions, Data Readouts, ESMO Presentations

(RTTNews) - The week that passed by saw shares of Nano-X Imaging Ltd. (NNOX) make the biggest weekly advance, gaining over 66%. The Israeli "digital X-ray device" maker made its debut on the Nasdaq as recently as August 21. Intra-Cellular Therapies Inc. (ITCI) was another healthcare stock that ended with a weekly gain of over 50%, thanks to positive topline results from a phase III study of Lumateperone in patients with bipolar depression.

Now, let's take a look at some of the stocks that merit attention in the coming week.

1. Autolus Therapeutics plc (AUTL)

Autolus is a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of hematological malignancies and solid tumors.

The company's clinical drug candidates include AUTO1, under a pivotal phase Ib/II trial in acute lymphocytic leukemia, and AUTO3, under a phase I/II trial in relapsed/refractory diffuse Large B Cell Lymphoma, dubbed ALEXANDER.
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«    Октябрь 2020    »